Vimarsana
Biggest News Aggregation in the World

Page 13 - Zymeworks Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zymeworks Inc Today - Breaking & Trending Today

5 Best Healthcare Stocks For the Long-Term - Vimarsana News

5 Best Healthcare Stocks For the Long-Term

In this piece, we will take a look at the five best healthcare stocks for the long term.

Zymeworks (NYSE:ZYME) Shares Up 3.8% - Vimarsana News

Zymeworks (NYSE:ZYME) Shares Up 3.8%

Zymeworks Inc. (NYSE:ZYME – Get Free Report)’s share price shot up 3.8% on Monday . The company traded as high as $8.47 and last traded at $8.45. 118,028 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 568,921 shares. The stock had previously closed at $8.14. Wall Street […]

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Hold" from Analysts - Vimarsana News

Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of "Hold" from Analysts

Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given an average rating of “Hold” by the seven brokerages that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective […]

Source: wkrb13.com
Zymeworks Inc. (NYSE:ZYME) Q3 2023 Earnings Call Transcript - Vimarsana News

Zymeworks Inc. (NYSE:ZYME) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Zymeworks Third Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode.

Monaco Asset Management SAM Purchases 10,420 Shares of Zymeworks Inc. (NYSE:ZYME) - Vimarsana News

Monaco Asset Management SAM Purchases 10,420 Shares of Zymeworks Inc. (NYSE:ZYME)

Monaco Asset Management SAM lifted its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 2.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 409,520 shares of the company’s stock after buying an additional 10,420 shares during the quarter. Zymeworks comprises […]